Evidence map›Paper›PMID 40671333›Full record

ReviewNeurourology and urodynamics2026

Genomics and Histopathology in Interstitial Cystitis/Bladder Pain Syndrome.

Hannah Ruetten, LaTasha K Crawford, Elise J B De, Wencheng Li, Yoshiyuki Akiyama

Abstract readReview
In one paragraph

Review in Neurourology and urodynamics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hannah RuettenWake Forest Institute for Regenerative Medicine, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA.ORCID https://orcid.org/0000-0001-6263-6221
LaTasha K CrawfordDepartment of Pathobiological Sciences, University of Wisconsin-Madison School of Veterinary Medicine, Madison, Wisconsin, USA.ORCID https://orcid.org/0000-0002-8553-9894
Elise J B DeDepartment of Urology, Albany Medical Center, Albany, New York, USA.ORCID https://orcid.org/0000-0003-0730-9038
Wencheng LiDepartment of Pathology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Yoshiyuki AkiyamaDepartment of Urology, Shinshu University School of Medicine, Matsumoto, Japan.

Funding

Laboratory Animal & Comparative Medicine TrainingT32OD010957 · OD · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI J. MARK CLINE · 2012 to 2026
$4.3M
NIDDK NIH HHS L70 DK140978NIH HHS T32 OD010957Ruetten is supported by NIH T32 OD010957 and NIH L70 DK140978. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
6 · The paper itself

Abstract

aimsIn April of 2025, a Global Consensus meeting on IC/BPS was held in Winston-Salem, NC. The goal of this meeting was to establish global consensus in diagnostic criteria, phenotyping, treatment outcome assessment, and possible etiopathology in interstitial cystitis/bladder pain syndrome (IC/BPS). Our sub-committee focused on developing a consensus document on histopathology in IC/BPS.

methodsNarrative review.

resultsHerein we discuss histological and molecular distinctions of Hunner lesion disease (HLD) and non-Hunner lesion disease (non-HLD) in IC/BPS, including urothelial alterations, inflammatory changes, vascularization and fibrosis, and neurophysiological dysfunction. The molecular and histological characteristics of HLD make it distinct from non-HLD. HLD is histologically characterized by urothelial denudation and subepithelial chronic inflammation featured by B-cell dominant lymphoplasmacytic infiltration, while non-HLD shows subtle inflammatory changes with preserved urothelial layers. Some cases of non-HLD reflect a component of multi-systemic pain syndrome driven by altered neurophysiological networks within the central or peripheral nervous system.

conclusionsMolecular and histological characteristics revealed that HLD and non-HLD are distinct disease entities as the former is an inflammatory disease of the urinary bladder and the latter may be represented by systemic neurophysiological disorder, rather than pathology that is limited to the bladder. This concept could be useful in phenotyping, diagnosis, and development of biomarkers for IC/BPS.

trial registrationNo new data were generated for this manuscript; no clinical trial was conducted.

Indexed as

Cystitis, InterstitialGenomicsUrinary BladderHumansUrotheliumhistologyHunner lesioninflammationmast cellneural dysfunctionpathology

Identifiers

PMID40671333
PMCPMC12748040

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.